RIGL is currently covered by 8 analysts with average potential upside of $3.19 (166.26%) backed by 52 price targets and 81 ratings. Documented since 26-Mar-2009. Analyst's average stock valuation to be materialised ratio is 13.33% with an average time for price targets to be met of 45.78 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 09-Mar-2023.
Highest price target for RIGL is 4, Lowest price target is 1, average price target is 2.5.
Currently, out of the existing stock ratings of RIGL - 11 which are a Buy (61.11%), 7 which are a Hold (38.89%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
3
$1.66 (123.88%)
22 days ago
0/1 (0%)
$1.32 (78.57%)
Buy
15
$13.66 (1019.40%)
15
23 days ago
0/5 (0%)
$7.68 (526.62%)
Buy
3
$1.66 (123.88%)
3
4 months 27 days ago
1/6 (16.67%)
$2.91 (178.12%)
65
Hold
2
$0.66 (49.25%)
8
7 months 14 days ago
1/10 (10%)
$3.8 (130.91%)
156
Hold
2
$0.66 (49.25%)
1
7 months 14 days ago
6/15 (40%)
$3.18 (112.33%)
125
What is RIGL(Rigel Pharmaceuticals, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RIGL(Rigel Pharmaceuticals, Inc) with a proven track record?
